Testing effectiveness (Phase 2)Not Yet RecruitingNCT07258641
What this trial is testing
Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease
Who this might be right for
Ulcerative Colitis (UC)Crohn Disease (CD)
University Medical Center Groningen 30